Week 14 2025 Mon 6/23-Sun 6/29 | |||||||||
| Team | Coach Rating | M | T | W | T | F | S | S | Total |
|---|---|---|---|---|---|---|---|---|---|
| (13-9) | 23 | 60 | 14 | 33 | 41 | 47 | 42 | 256 | |
| (14-8) | 11 | 48 | 84 | 6 | 52 | 42 | 53 | 293.5 | |
| Final Non-Division Game | |||||||||
| Name | Opp | Stats | Day | Total | Pos | Total | Day | Stats | Opp | Name | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
C TOR | — | 19.5 | C | — | — | 10DI. Herrera C/DH STL | ||||||
1B LAA | 0-5 AVG | -1 | 12 | 1B | 13.5 | -1 | 0-4 AVG | 1B BAL | ||||
2B CHC | 2-3 AVG | 2 | 32 | 2B | 9.5 | — | OUTJ. Altuve 2B/LF/DH HOU | |||||
SS ATH | — | 5.5 | SS | 3.5 | — | 2B/SS/3B/LF/RF NYY | ||||||
3B TB | — | 11.5 | 3B | 1.5 | — | DTDJ. Westburg 2B/3B/DH BAL | ||||||
2B/SS/3B/CF DET | — | 2.5 | OF | 6.5 | 1.5 | 2-4 AVG | CF CIN | |||||
RF NYM | 1-4 AVG 2 RBI | 6.5 | 34 | OF | 23.5 | — | LF/CF/DH DET | |||||
LF/DH WSH | 3-5 AVG 4 RBI | 12 | 29 | OF | 20.5 | 7 | 1-4 AVG 2 RBI | 2B/LF STL | ||||
LF TEX | 1-3 AVG | 3 | 13 | UTIL | 22 | — | 1B/DH TB | |||||
SP FA | — | 26.5 | SP | 16 | — | OUTZ. Wheeler SP PHI | ||||||
SP BOS | — | 48.5 | SP | 41.5 | — | SP BOS | ||||||
SP ATH | — | 1.5 | SP | 29.5 | — | SP NYY | ||||||
SP WSH | — | -5.5 | SP | 51.5 | — | SP DET | ||||||
OUTT. Scott RP LAD | — | 26 | RP | 17 | 3 | 0.2 IP | RP ATL | |||||
SP MIN | — | — | RP | 4.5 | — | RP BAL | ||||||
SP KC | — | -2 | RP | — | — | SP SEA | ||||||
SP ATL | — | 2 | P | 33 | — | SP LAA | ||||||
| Total | 22.5 | 256 | 293.5 | 10.5 | Total | |||||||
| Optimum | 23.5 | 287 | 324.5 | 18 | Optimum | |||||||
Benched | ||||||||||||
1B/LF ATH | — | 8 | BN | — | — | 3B SF | ||||||
OUTC. Carroll RF ARI | — | — | BN | 19.5 | 6.5 | 2-4 AVG 1 RBI | SS/3B HOU | |||||
1B/DH KC | — | 20 | BN | — | — | RF/DH TOR | ||||||
SP CIN | — | 10 | BN | 14.5 | — | SP CLE | ||||||
| BN | 13 | — | RP NYM | |||||||||
| Total | 0 | 38 | 47 | 6.5 | Total | |||||||
Injured Reserve | ||||||||||||
SP LAD | — | — | IL | — | — | 15DN. Eovaldi SP TEX | ||||||
SP SF | — | — | IL | — | — | SP PHI | ||||||